Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translationAMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGYIF3.52022-11-014OA
Attached stratified mucus separates bacteria from the epithelial cells in COPD lungsJCI INSIGHTIF6.12018-09-0636OAAI
Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy SubjectsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52018-04-1675OAAI
Target engagement confirmed in man with a dipeptidyl peptidase 1 inhibitorEUROPEAN RESPIRATORY JOURNALIF212017-12-064PRE
Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway DiseaseJOURNAL OF IMMUNOLOGY RESEARCHIF3.62017-01-0126OAAI
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)JOURNAL OF MEDICINAL CHEMISTRYIF6.82016-10-1173PREAI
Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibitionAMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGYIF3.52015-01-0165OAAI
Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C) Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and 5-HT2B ReceptorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-06-1729PREAI
Opioid receptor characterisation of neuronally stimulated isolated human vas deferens神经刺激的离体人输精管的阿片受体表征NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYIF3.12012-06-153PREAI
In vitro and in vivo characterization of PF-044189948, a novel, potent and selective prostaglandin EP2 receptor antagonistBRITISH JOURNAL OF PHARMACOLOGYIF7.72011-11-15139OAAI